$OMER Cashflow Statement | Understand Stock

$OMER

$17.49 +$1.20 (7.37%) Close

$OMER Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating activities:
Net loss
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Gain on sale of zaltenibart
Remeasurement on fair value of financial instruments
Stock-based compensation expense
Depreciation and amortization
(Gain) loss on early extinguishment of debt
Convertible Senior Notes 2026
Initial Term Loan
Amortization of discount and issuance costs on debt
Initial Term Loan
Convertible Debt
Loans Payable
Total amortization of discount and issuance costs on debt
Non-cash interest remeasurement on the OMIDRIA royalty obligation
Noncash adjustments on buyout of equipment finance leases
Non-cash interest on OMIDRIA contract royalty asset
Remeasurement on OMIDRIA contract royalty asset
Accretion on U.S. government treasury bills, net
Gain on sale of OMIDRIA, gross

Changes in operating assets and liabilities:
OMIDRIA contract royalty asset
Accounts payable and accrued expense
Receivables
Prepaid expenses and other
Accounts payable and other expense
Other liabilities non-current
Net cash provided by (used in) operating activities

Investing activities:
Gross cash proceeds from sale of zaltenibart
Proceeds from the sale and maturities of investments
Purchases of investments
Purchases of property and equipment
Proceeds from Divestiture of Businesses
Net cash provided by investing activities
Financing activities:
Proceeds upon exercise of stock options
Repayment of term debt principal
Principal payments on OMIDRIA royalty obligation
Prepayment premium and transaction costs on repayment of term debt
Payment of debt issuance costs related to 2029 Notes
Payments on finance lease obligations
At the market offering costs
Proceeds from sale of future royalties
Payment on maturity of 2023 Notes
Cash paid to repurchase 2026 Notes
Repurchases of common stock
Net cash provided by (used in) financing activities
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Supplemental cash flow information
Exchange of 2026 Notes for 2029 Notes
Conversion of the 2026 Notes Into 2029 Notes
Conversion of the 2026 Notes Into Common Stock
Cash paid for interest
Cash paid for income taxes, net
Equipment acquired under finance lease

Comments